Skip to main content
Log in

Diminished energy metabolism and enhanced apoptosis in livers of B6C3F1 mice treated with the antihepatocarcinogen rotenone

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Rotenone decreases the incidence of hepatocellular carcinoma and lowers rates of hepatocellular proliferation. In an effort to delineate mechanisms involved, the in vivo effect of rotenone on liver mitochondrial metabolism, apoptotic machinery as well as elements of the hepatic signal transduction pathways were investigated. Mitochondria from livers of male B6C3F1 mice fed a standard diet containing 600 ppm rotenone for 7 days were uncoupled or inhibited when succinate or glutamate plus malate were used as the substrate, respectively. These livers also showed a significant increase in apoptosis compared with control livers. Furthermore, rotenone increased the expression of c-myc mRNA to 5-fold of control values within 3 days, an effect which was still observed (3-fold) after 7 days. Levels of p53 mRNA were also increased 3-fold after 1 day, but declined to control levels by 7 days. Rotenone also caused a transient, yet marked increase in liver particulate glyceraldehyde phosphate dehydrogenase (GAPDH) protein expression, while it did not alter the expression of the cytosolic form of the enzyme. Conversely, mRNA of the proto-oncogene H-ras showed a decline of 35% after 3 days of rotenone treatment, and remained diminished for the duration of the experiment. These data suggest that rotenone may act as an anticancer agent by diminishing mitochondrial bioenergetics which prevents basal hepatocyte proliferation and lowers the threshold for liver cells with DNA damage to undergo apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cunningham ML, Soliman MS, Badr MZ, Matthews HB: Rotenone, an anticarcinogen, inhibits cellular proliferation but not peroxisome proliferation in mouse liver. Cancer Lett 95: 93–97, 1995

    Google Scholar 

  2. Isenberg J, Kolaja K, Ayoubi S, Watkins III J, Klaunig J: Inhibition of WY-14, 643 induced hepatic lesion growth in mice by rotenone. Carcinogenesis 18: 1511–1519, 1997

    Google Scholar 

  3. Oberg K: Site of action of rotenone in the respiration chain. Exp Cell Res 24:163–164, 1961

    Google Scholar 

  4. Arora K, Pedersen P: Functional significance of mitochondrial bound hexokinase in tumor cell metabolism: evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP. J Biol Chem 263: 17422–17428, 1988

    Google Scholar 

  5. Rogers AE, Zeisel SH, Groopman J: Diet and carcinogenesis. Carcinogenesis 14: 2205–2217, 1993

    Google Scholar 

  6. Ellis R, Yuan J, Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol 7: 663–689, 1991

    Google Scholar 

  7. Wolvetang E, Johnson K, Krauer K, Ralph S, Linnane A: Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett 339: 40–44, 1994

    Google Scholar 

  8. Parsons D, Williams G, Chance B: Characteristics of isolated and purified preparations of the outer and inner membranes of mitochondria. Ann NY Acad Sci 137: 643–666, 1966

    Google Scholar 

  9. Chance B, Williams G: Respiratory enzymes in oxidative phosphorylation. J Biol Chem 217: 383–393, 1955

    Google Scholar 

  10. Heruth DP, Wetmore LA, Leyva A, Rothberg PG: The influence of protein tyrosine phosphorylation on the expression of c-myc oncogene in cancer of the large bowel. J Cell Biochem 58: 83–94, 1995

    Google Scholar 

  11. Rothberg PG, Erisman MD, Diehl RE, Rovigatti UG, Astrin SM: Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoitic malignancies. Mol Cell Biol 4: 1096–1103, 1984

    Google Scholar 

  12. Matlashewski G, Lamb P, Pim D, Peacock J, Crawford L, Benchimol S: Isolation and characterization of a human p53 cDNA clone: Expression of the human p53 gene. EMBO J 3: 3257–3262, 1984

    Google Scholar 

  13. Miesfeld R, Arnheim N: Identification of the in vivo and in vitro origin of transcription in human rDNA. Nucleic Acid Res 10: 3933–3949, 1982

    Google Scholar 

  14. Tabin CJ, Bradly SM, Bargman CI, Weinberg RA, Papageorge AG, Scolnick EM, Dhar R, Lowry DR, Chang EH: Mechanism of a human oncogene. Nature 300: 143–148, 1982

    Google Scholar 

  15. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH: Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76–85, 1985

    Google Scholar 

  16. Grasl-Kraupp B, Bursch W, Ruttkay-Nedecky B, Wagner A, Lauer B, Schulte-Hermann R: Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Natl Acad Sci (USA) 91: 9995–9999, 1994

    Google Scholar 

  17. Yarbrough J, Cunningham M, Yamanaka H, Thurman R, Badr M: Carbohydrate and oxygen metabolism during hepatocellular proliferation: a study in perfused livers from mirex-treated rats. Hepatology 13: 1229–1234, 1991

    Google Scholar 

  18. Nagino M, Tanaka M, Nishikimi M, Nimura Y, Kubata H, Kanai M, Kato T, Ozawa T: Stimulated rat liver mitochondrial biogenesis after partial hepatectomy. Cancer Res 49: 4913–4918, 1989

    Google Scholar 

  19. Ernester L, Dallner C, Azzone G: Differential effects of rotenone and amytal on mitochondrial electron and energy transfer. J Biol Chem 238: 1124–1131, 1963

    Google Scholar 

  20. Bereznowski Z: Effect of methyl methacrylate on mitochondrial function and structure. Int J Biochem 26: 1119–1127, 1994

    Google Scholar 

  21. Winberg L, Badr M: Mechanism of phthalate-induced inhibition hepatic mitochondrial β-oxidation. Toxicol Lett 76: 63–69, 1995

    Google Scholar 

  22. Barham S, Brinkley B: Action of rotenone and related respiratory inhibitors on mammalian cell division. 2. Ultrastructural studies. Cytobios 15: 97–109, 1976

    Google Scholar 

  23. Eguchi Y, Shimizu S, Tsujimoto Y: Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 57: 1835–1840, 1977

    Google Scholar 

  24. Shimamatsu K, Wanless IR: Role of ischemia in causing apoptosis, atrophy and nodular hyperplasis in human liver. Hepatology 26: 343–350, 1997

    Google Scholar 

  25. Saunders P, Chalecka-Franaszek E, Chuang D-M: Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine Arabinoside-induced apoptosis. J Neurochem 69: 1820–1828, 1997

    Google Scholar 

  26. Huitorel P, Pantaloni D: Bundling of microtubules by GAPDH and its modulation by ATP. Eur J Biochem 150: 265–269, 1985

    Google Scholar 

  27. Gelfand V: Microtubule dynamics: mechanism, regulation and function. Annu Rev Cell Biol 7: 93–116, 1991

    Google Scholar 

  28. Hermeking H, Eick D: Mediation of c-myc induced apoptosis by p53. Science 265: 2091–2093, 1994

    Google Scholar 

  29. Kohlhuber F, Hermeking H, Graessmann A, Eick D: Induction of apoptosis by the c-myc helix-loop-helix/leucine zipper domain in mouse 3T3-L1 fibroblasts. J Biol Chem 270: 28797–28805, 1995

    Google Scholar 

  30. Morgan S, Kastan M: p53 and ATM. In: G. Woude, G. Klein (eds). Cell cycle, Cell Death, and Cancer. Adv Cancer Res. Academic Press, San Diego, vol. 71, 1997, pp 1–25

    Google Scholar 

  31. Stanley LA: Molecular aspects of chemical carcinogenesis: The roles of oncogenes and tumour suppressor genes. Toxicology 96: 173–194, 1995

    Google Scholar 

  32. Depinho RA, Schreiber-Argus N, Alt FW: MYC family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res 57: 1–46, 1991

    Google Scholar 

  33. Rothberg PG, Heruth DP: Adventures in MYC-ology. Adv in Genome Biol 3B: 337–414, 1995

    Google Scholar 

  34. Horikawa S, Skata K, Hatanaka M, Tsukadato K: Expression of c-myc oncogene in rat liver by a dietary manipulation. Biochem Biophys Res Commun 140: 574–580, 1986

    Google Scholar 

  35. Mead JE, Braun L, Martin DA, Fausto N: Induction of replicative competence ('Priming') in normal liver. Cancer Res 50: 7023–7030, 1990

    Google Scholar 

  36. Saito Y, Ogawa K: Wild type p53 and c-myc co-operation in generating apoptosis of a rat hepatocellular carcinoma cell line (FAA-HTC1). Oncogene 11: 1013–1018, 1995

    Google Scholar 

  37. Goyette M, Petropoulos CG, Shank PR, Fausto N: Expression of a cellular oncogenes during liver regeneration. Science 219: 510–512, 1983

    Google Scholar 

  38. Crawford J: The liver and the biliary tract. In: R. Cotran, V. Kumar, T. Collins (eds). Robbins Pathologic Basis of Disease, sixth edition. W.B. Saunders Company, Philadelphia, 1998, pp 845–901

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, C., Youssef, J., Saran, B. et al. Diminished energy metabolism and enhanced apoptosis in livers of B6C3F1 mice treated with the antihepatocarcinogen rotenone. Mol Cell Biochem 201, 25–32 (1999). https://doi.org/10.1023/A:1007024905046

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007024905046

Navigation